VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 72 filers reported holding VERASTEM INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $168,000 | +11.3% | 16,500 | 0.0% | 0.06% | -8.3% |
| Q4 2014 | $151,000 | +7.1% | 16,500 | 0.0% | 0.06% | +15.4% |
| Q3 2014 | $141,000 | -5.4% | 16,500 | 0.0% | 0.05% | -26.8% |
| Q2 2014 | $149,000 | -16.3% | 16,500 | 0.0% | 0.07% | -9.0% |
| Q1 2014 | $178,000 | -5.3% | 16,500 | 0.0% | 0.08% | -9.3% |
| Q4 2013 | $188,000 | -8.3% | 16,500 | 0.0% | 0.09% | -29.5% |
| Q3 2013 | $205,000 | -10.5% | 16,500 | 0.0% | 0.12% | -10.9% |
| Q2 2013 | $229,000 | – | 16,500 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |